Evidence map›Paper›PMID 15483629›Full record

ArticleThe EMBO journal2004

Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible.

Hiromi Tagoh, Alexandra Schebesta, Pascal Lefevre, Nicola Wilson, David Hume, Meinrad Busslinger, Constanze Bonifer

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  3. Article
  4. Article
  5. CSF-1 receptor signaling in myeloid cells.Cold Spring Harbor perspectives in biology · 2014
    Review
  6. Article
  7. Article
  8. Article
  9. Hematopoiesis.Cold Spring Harbor perspectives in biology · 2012
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Hiromi TagohMolecular Medicine Unit, St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK.
Alexandra Schebesta
Pascal Lefevre
Nicola Wilson
David Hume
Meinrad Busslinger
Constanze Bonifer
Research Institute of Molecular Pathology · ATSt James's University Hospital · GBUniversity of Leeds · GBUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The murine c-fms (Csf1r) gene encodes the macrophage colony-stimulating factor receptor, which is essential for macrophage development. It is expressed at a low level in haematopoietic stem cells and is switched off in all non-macrophage cell types. To examine the role of chromatin structure in this process we studied epigenetic silencing of c-fms during B-lymphopoiesis. c-fms chromatin in stem cells and multipotent progenitors is in the active conformation and bound by transcription factors. A similar result was obtained with specified common myeloid and lymphoid progenitor cells. In developing B cells, c-fms chromatin is silenced in distinct steps, whereby first the binding of transcription factors and RNA expression is lost, followed by a loss of nuclease accessibility. Interestingly, regions of de novo DNA methylation in B cells overlap with an intronic antisense transcription unit that is differently regulated during lymphopoiesis. However, even at mature B cell stages, c-fms chromatin is still in a poised conformation and c-fms expression can be re-activated by conditional deletion of the transcription factor Pax5.

Indexed as

ChromatinEpigenesis, GeneticGenes, fmsGene SilencingAnimalsB-LymphocytesDNA MethylationGene Expression RegulationHistonesLymphopoiesisMiceNucleic Acid ConformationPluripotent Stem CellsPromoter Regions, GeneticRNA, AntisenseTranscription FactorsChromatinHistonesRNA, AntisenseTranscription Factors

Identifiers

PMID15483629
PMCPMC524389
OpenAlexW2109810456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.